
|Articles|March 4, 2014
- Vol 31 No 3
- Volume 31
- Issue 3
Data Point
Author(s)Richard M. Berlin, MD
Three years deep in despair, he’s swallowed every pill I prescribed...
Advertisement
While reviewing the results of a drug study for treatment-resistant depression
Three years deep in despair, he’s swallowed
every pill I prescribed. Refusing ECT,
his family and I convinced him to give
research medication one last shot.
Unblinded data arrived today and glows
on my computer screen, each depressed
patient’s response graphed with a dot,
the experimental molecule clearly beating
placebo, my patient’s outlier point six feet under
the rising line of success, a speck of coal
on a snow-covered field, my mind expanding
the insignificant dot to a skull’s eye socket
staring me down like a Beretta’s bullet hole.
Articles in this issue
over 12 years ago
The New CPT Codes: Ethical Challenges in a New Billing Era?over 12 years ago
End-of-Life Decisions: Who Decides and the Role of the Psychiatristover 12 years ago
Revive Flurothyl Inhalation Therapyover 12 years ago
Prescribing Psychotropics for Women of Childbearing Potentialover 12 years ago
Introduction: The Brave New World of Psychiatric Ethicsover 12 years ago
Ethics and Virtues in Clinical PsychiatryAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Vol 43, Issue 7 - Interactive
2
Psychedelics, Orexin Blockers, and More: Inside the Diverse New Pipeline for Depression
3
Long-Acting Injectables in Schizophrenia: Closing the Gap Between Evidence and Practice
4
COMP360 Psilocybin in Treatment-Resistant Depression: Insights From Gus Alva, MD, DFAPA
5










